CONFIRM anti-CD79a (SP18) Rabbit Monoclonal Primary Antibody is intended for the detection of CD79a in normal and neoplastic human tissues. Anti-CD79a is directed against a protein expressed on the surface of B lymphocytes at all stages of maturation, from B lymphocyte precursors through plasma cells. Expression of CD79a may aid in the identification of B cell lineage in malignant lymphomas.
| Ventana Medical Systems, Inc. | |
|---|---|
| Product Category | Organic Chemicals |
| Product Number | 790-4432 |
| Product Name | CONFIRM CD79a |
